Advanced BioMedical Technologies (OTCMKTS:ABMT) and Heart Test Laboratories (NASDAQ:HSCS) Head-To-Head Comparison

Heart Test Laboratories (NASDAQ:HSCS) and Advanced BioMedical Technologies (OTCMKTS:ABMT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Analyst Ratings

This is a summary of current ratings and target prices for Heart Test Laboratories and Advanced BioMedical Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0	0	2	0	3.00
Advanced BioMedical Technologies	0	0	0	0	0.00

Heart Test Laboratories currently has a consensus price target of $13.50, indicating a potential upside of 289.05%. Given Heart Test Laboratories’ stronger consensus rating and higher possible upside, equities analysts clearly believe Heart Test Laboratories is more favorable than Advanced BioMedical Technologies.

Earnings and Valuation

This table compares Heart Test Laboratories and Advanced BioMedical Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	$20,000.00	170.03	-$6.61 million	($7.91)	-0.44
Advanced BioMedical Technologies	$270,000.00	N/A	-$510,000.00	N/A	N/A

Advanced BioMedical Technologies has higher revenue and earnings than Heart Test Laboratories.

Institutional & Insider Ownership

17.2% of Heart Test Laboratories shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Comparatively, 34.1% of Advanced BioMedical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Heart Test Laboratories and Advanced BioMedical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	-117.76%	-84.09%
Advanced BioMedical Technologies	N/A	N/A	N/A

Volatility and Risk

Heart Test Laboratories has a beta of 2.9, suggesting that its share price is 190% more volatile than the S&P 500. Comparatively, Advanced BioMedical Technologies has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

About Advanced BioMedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.